Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles

BACKGROUND: The hepatitis B virus core (HBc) particle is known as a promising new carrier for the delivery of drugs and nucleic acids. However, since the arginine-rich domain that is located in the C-terminal region of the HBc monomer binds to the heparan sulphate proteoglycan on the cell surface du...

Full description

Bibliographic Details
Main Authors: Mohamed Suffian, Izzat Fahimuddin, Nishimura, Yuya, Morita, Kenta, Nakamura-Tsuruta, Sachiko, Al-Jamal, Khuloud, Ishii, Jun, Ogino, Chiaki, Kondo, Akihiko
Format: Article
Language:English
Published: Biomed Central 2015
Subjects:
Online Access:http://irep.iium.edu.my/57364/
http://irep.iium.edu.my/57364/
http://irep.iium.edu.my/57364/1/Suffian%20et%20al.%20Journal%20of%20Nanobiotechnology.pdf
id iium-57364
recordtype eprints
spelling iium-573642017-06-23T00:04:31Z http://irep.iium.edu.my/57364/ Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles Mohamed Suffian, Izzat Fahimuddin Nishimura, Yuya Morita, Kenta Nakamura-Tsuruta, Sachiko Al-Jamal, Khuloud Ishii, Jun Ogino, Chiaki Kondo, Akihiko QH301 Biology QR355 Virology RM Therapeutics. Pharmacology BACKGROUND: The hepatitis B virus core (HBc) particle is known as a promising new carrier for the delivery of drugs and nucleic acids. However, since the arginine-rich domain that is located in the C-terminal region of the HBc monomer binds to the heparan sulphate proteoglycan on the cell surface due to its positive charge, HBc particles are introduced non-specifically into a wide range of cells. To avoid non-specific cellular uptake with the intent to control the ability of cell targeting, we individually replaced the respective arginine (R) residues of the arginine-rich domain located in amino acid positions 150-159 in glycine (G) residues. RESULTS: The mutated HBc particles in which R154 was replaced with glycine (G) residue (R154G) showed a drastic decrease in the ability to bind to the heparan sulphate proteoglycan and to avoid non-specific cellular uptake by several types of cancer cells. CONCLUSIONS: Because this mutant particle retains most of its C-terminal arginine-rich residues, it would be useful in the targeting of specificity-altered HBc particles in the delivery of nucleic acids. Biomed Central 2015-02-13 Article PeerReviewed application/pdf en http://irep.iium.edu.my/57364/1/Suffian%20et%20al.%20Journal%20of%20Nanobiotechnology.pdf Mohamed Suffian, Izzat Fahimuddin and Nishimura, Yuya and Morita, Kenta and Nakamura-Tsuruta, Sachiko and Al-Jamal, Khuloud and Ishii, Jun and Ogino, Chiaki and Kondo, Akihiko (2015) Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles. Nanobiotechnology, 13. ISSN 1477-3155 http://dx.doi.org/10.1186/s12951-015-0074-8
repository_type Digital Repository
institution_category Local University
institution International Islamic University Malaysia
building IIUM Repository
collection Online Access
language English
topic QH301 Biology
QR355 Virology
RM Therapeutics. Pharmacology
spellingShingle QH301 Biology
QR355 Virology
RM Therapeutics. Pharmacology
Mohamed Suffian, Izzat Fahimuddin
Nishimura, Yuya
Morita, Kenta
Nakamura-Tsuruta, Sachiko
Al-Jamal, Khuloud
Ishii, Jun
Ogino, Chiaki
Kondo, Akihiko
Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles
description BACKGROUND: The hepatitis B virus core (HBc) particle is known as a promising new carrier for the delivery of drugs and nucleic acids. However, since the arginine-rich domain that is located in the C-terminal region of the HBc monomer binds to the heparan sulphate proteoglycan on the cell surface due to its positive charge, HBc particles are introduced non-specifically into a wide range of cells. To avoid non-specific cellular uptake with the intent to control the ability of cell targeting, we individually replaced the respective arginine (R) residues of the arginine-rich domain located in amino acid positions 150-159 in glycine (G) residues. RESULTS: The mutated HBc particles in which R154 was replaced with glycine (G) residue (R154G) showed a drastic decrease in the ability to bind to the heparan sulphate proteoglycan and to avoid non-specific cellular uptake by several types of cancer cells. CONCLUSIONS: Because this mutant particle retains most of its C-terminal arginine-rich residues, it would be useful in the targeting of specificity-altered HBc particles in the delivery of nucleic acids.
format Article
author Mohamed Suffian, Izzat Fahimuddin
Nishimura, Yuya
Morita, Kenta
Nakamura-Tsuruta, Sachiko
Al-Jamal, Khuloud
Ishii, Jun
Ogino, Chiaki
Kondo, Akihiko
author_facet Mohamed Suffian, Izzat Fahimuddin
Nishimura, Yuya
Morita, Kenta
Nakamura-Tsuruta, Sachiko
Al-Jamal, Khuloud
Ishii, Jun
Ogino, Chiaki
Kondo, Akihiko
author_sort Mohamed Suffian, Izzat Fahimuddin
title Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles
title_short Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles
title_full Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles
title_fullStr Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles
title_full_unstemmed Mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis B virus core particles
title_sort mutation of arginine residues to avoid non-specific cellular uptakes for hepatitis b virus core particles
publisher Biomed Central
publishDate 2015
url http://irep.iium.edu.my/57364/
http://irep.iium.edu.my/57364/
http://irep.iium.edu.my/57364/1/Suffian%20et%20al.%20Journal%20of%20Nanobiotechnology.pdf
first_indexed 2023-09-18T21:21:05Z
last_indexed 2023-09-18T21:21:05Z
_version_ 1777411886523875328